Psychiatric safety of ketamine in psychopharmacology research
- 16 February 2007
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 192 (2), 253-260
- https://doi.org/10.1007/s00213-007-0706-2
Abstract
A growing number of investigators are studying ketamine effects in healthy human subjects, but concerns remain about its safety as a research tool. Therefore, it is timely to revisit the safety of subanesthetic doses of ketamine in experimental psychopharmacology studies.Keywords
This publication has 45 references indexed in Scilit:
- Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of AlcoholismNeuropsychopharmacology, 2006
- Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to AlcoholismAmerican Journal of Psychiatry, 2004
- Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy VolunteersNeuropsychopharmacology, 2003
- Effects of Ketamine in Normal and Schizophrenic VolunteersNeuropsychopharmacology, 2001
- NMDA-Sensitive Glutamate Antagonism A Human Model for PsychosisNeuropsychopharmacology, 1999
- NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disordersHarvard Review of Psychiatry, 1999
- Ketamine: an update on the first twenty-five years of clinical experienceCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1989
- Comparison of Ketamine and Thiopental in Healthy VolunteersAnesthesia & Analgesia, 1984
- Reliabilities and intercorrelations of eight measures of proneness to psychosis.Journal of Consulting and Clinical Psychology, 1982
- Reliabilities and intercorrelations of eight measures of proneness to psychosis.Journal of Consulting and Clinical Psychology, 1982